DNTH

NASD Dianthus Therapeutics, Inc.
Oct 10, 2026 · 12:09 PM ET EOD Market Closed

$82.37 ↑ +0.00 (+0.00%) Trading Up from the previous close of $82.37, $2.83 below the day’s high of $85.20

YTD change
+99.88%
vs 20-day SMA
-11.76%
vs 200-day SMA
+0.43%

Price ranges

Previous day
$82.13 $85.20
open $82.36 close $82.37
+$0.01 (+0.01%)
Today
$82.13 $85.20
$82.37
Past week
$81.06 $91.24
from $88.32 now $82.37
-$5.95 (-6.74%)
Past month
$81.06 $109.79
from $103.28 now $82.37
-$20.91 (-20.25%)
This year
$35.84 $117.88
from $41.21 now $82.37
+$41.16 (+99.88%)

Price & Performance

-7.40 (-8.24%) / 6M

$73.26$88.55$103.83$119.12Apr 10Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 30.1% away from all-time highs of $117.88
  • DNTH is up 100% since the beginning of the year
  • DNTH is up 137% over the past 12 months
  • DNTH is down 20% over the past 1 month
  • 16% of all DNTH investors are betting against DNTH

DNTH reads not so good: price sits above one of the two key moving averages, the 12-month move is +139.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.9
Earnings momentum +4.6% Quarterly EPS growth
Quarterly change +4.6%

Valuation

P/E ratio N/A
Enterprise value $3.7B
Beta 0.18

Balance sheet & scale

IncomeN/A
Revenue$1.9M
Cash$886.8M
Debt$1.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $4.6B

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.